Advertisement

International Ophthalmology

, Volume 26, Issue 4–5, pp 135–141 | Cite as

Dilute triamcinolone-assisted peeling of the internal limiting membrane in cases of diffuse diabetic macular oedema

  • Remzi Avci
  • Berrin Avci
  • Berkant Kaderli
Original Paper

Abstract

Purpose

In this study we evaluated the efficiency of diluted triamcinolone particles in peeling of the internal limiting membrane (ILM) in cases of diffuse diabetic macular oedema.

Methods

A prospective observational study of thirteen consecutive patients with diffuse diabetic macular oedema who had undergone ILM peeling aided by use of a diluted (1 mg mL−1) suspension of triamcinolone particles (0.05 mg). The results were assessed by measurement of visual acuity and intraocular pressure, by ophthalmoscopy, and by fluorescein angiography.

Results

ILM peeling in all eyes could be performed easily and completely with the aid of triamcinolone particles homogeneously dispersed over the macular ILM. During the peeling procedure, triamcinolone particles resulted in clear contrast between the peeled and unpeeled ILM thus enabling us to easily find the edge of the ILM and to be able to continue peeling at further attempts. In twelve of the thirteen eyes the macular oedema was completely resolved or reduced. Visual acuity improved by at least two lines in nine eyes (70%). The intraocular pressure increase did not exceed 21 mmHg in any of the patients.

Conclusions

The diluted triamcinolone suspension enables good visualisation of the ILM during the ILM peeling procedure in cases of diffuse diabetic macular oedema. Use of a diluted suspension may reduce the risk of intraocular pressure increase and the potential toxicity of triamcinolone.

Keywords

Diffuse diabetic macular oedema Internal limiting membrane peeling Triamcinolone acetonide 

References

  1. 1.
    Clarkson JG, Green WR, Massof D (1977) A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol 84:1–17PubMedGoogle Scholar
  2. 2.
    Smiddy WE, Green WR, Michels RG, de la Cruz Z (1989) Ultrastructural studies of vitreomacular traction syndrome. Am J Ophlhalmol 107:177–185Google Scholar
  3. 3.
    Smiddy WE, Michels RG, Green WR (1990) Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina 10:288–296PubMedGoogle Scholar
  4. 4.
    Dillinger P, Mester U (2004) Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 242:630–637PubMedCrossRefGoogle Scholar
  5. 5.
    Smiddy WE, Feuer W, Cordahi G (2001) Internal limiting membrane peeling in macular hole surgery. Am J Ophthalmol 108:1471–1478Google Scholar
  6. 6.
    Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S (2000) Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 118:1116–1118PubMedGoogle Scholar
  7. 7.
    Burk SE, Da Mata AP, Snyder ME, Rosa RH, Foster RE (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107:2010–2014PubMedCrossRefGoogle Scholar
  8. 8.
    Avci R, Avci B, Kaderli B, Cavusoglu I (2004) A new surgical approach for indocyanine green-assisted internal limiting membrane peeling. Ophthalmic Surg Lasers Imaging 35:292–297PubMedGoogle Scholar
  9. 9.
    Vote BJ, Russell MK, Joondeph BC (2004) Trypan blue-assisted vitrectomy. Retina 24:736–738PubMedCrossRefGoogle Scholar
  10. 10.
    Horiguchi M, Nagata S, Yamamoto N, Kojima Y, Shimada Y (2003) Kinetics of indocyanine green dye after intraocular surgeries using indocyanine green staining. Arch Ophthalmol 121:327–331PubMedGoogle Scholar
  11. 11.
    Tadayoni R, Paques M, Girmens JF, Massin P, Gaudric A (2003) Persistence of fundus fluorescence after use of indocyanine green for macular surgery. Ophthalmology 110:604–608PubMedCrossRefGoogle Scholar
  12. 12.
    Gandorfer A, Haritoglou C, Gass CA, Ulbig MW, Kampik A (2001) Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 132:431–433PubMedCrossRefGoogle Scholar
  13. 13.
    Engelbrecht NE, Freeman J, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr, Martin DF et al (2002) Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 133:89–94PubMedCrossRefGoogle Scholar
  14. 14.
    Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A (2002) Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 134:836–841PubMedCrossRefGoogle Scholar
  15. 15.
    Enaida H, Sakamoto T, Hisatomi T, Goto Y, Ishibashi T (2002) Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol 240:209–213PubMedCrossRefGoogle Scholar
  16. 16.
    Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20:554–555PubMedGoogle Scholar
  17. 17.
    Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K et al (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423–429PubMedCrossRefGoogle Scholar
  18. 18.
    Kimura H, Kuroda S, Nagata M (2004) Triamcinolone acetonide-assisted peeling of the internal limiting membrane. Am J Ophthalmol 137:172–173PubMedCrossRefGoogle Scholar
  19. 19.
    Horio N, Horiguchi M, Yamamoto N (2005) Triamcinolone-assisted internal limiting membrane peeling during idiopathic macular hole surgery. Arch Ophthalmol 123:96–99PubMedCrossRefGoogle Scholar
  20. 20.
    Furino C, Micelli Ferrari T, Boscia F, Cardascia N, Recchimurzo N, Sborgia C (2003) Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina 23:771–776PubMedCrossRefGoogle Scholar
  21. 21.
    Sakamoto T, Koga H, Noda Y, Ishibashi T (2002) Optic disk cup filled with triamcinolone. Retina 22:516–518PubMedCrossRefGoogle Scholar
  22. 22.
    Takeuchi M, Katagiri Y, Usui M (2003) Residual triamcinolone acetonide in the macular hole after vitrectomy. Am J Ophthalmol 136:1174–1176PubMedCrossRefGoogle Scholar
  23. 23.
    Karacorlu M, Ozdemir H, Arf Karacorlu S (2005) Does intravitreal triamcinolone acetonide-assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery? Graefes Arch Clin Exp Ophthalmol 243:754–757PubMedCrossRefGoogle Scholar
  24. 24.
    Enaida H, Sakamoto T, Ueno A, Nakamura T, Noda Y, Maruoka K, Ishibashi T (2003) Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy. Am J Ophthalmol 135:243–246PubMedCrossRefGoogle Scholar
  25. 25.
    Fraser EA, Cheema RA, Roberts MA (2003) Triamcinolone acetonide-assisted peeling of retinal internal limiting membrane for macular surgery. Retina 23:883–884PubMedCrossRefGoogle Scholar
  26. 26.
    Takasu I, Shiraga F, Otsuki H (2004) Triamcinolone acetonide-assisted internal limiting membrane peeling in macular hole surgery. Retina 24:620–622PubMedCrossRefGoogle Scholar
  27. 27.
    Nakazawa F, Matsuno H, Yudoh K, Watanabe Y, Katayama R, Kimura T (2002) Corticosteroid treatment induces chondrocyte apoptosis in an experimental arthritis model and in chondrocyte cultures. Clin Exp Rheumatol 20:773–781PubMedGoogle Scholar
  28. 28.
    Dorscheid DR, Wojcik KR, Sun S, Marroquin B, White SR (2001) Apoptosis of airway epithelial cells induced by corticosteroids. Am J Respir Crit Care Med 164:1939–1947PubMedGoogle Scholar
  29. 29.
    Yeung CK, Chan KP, Chan CK, Pang CP, Lam DS (2004) Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone. Jpn J Ophthalmol 48:236–242PubMedCrossRefGoogle Scholar
  30. 30.
    Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD (2006) Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 47:722–728PubMedCrossRefGoogle Scholar
  31. 31.
    Yeung CK, Chan KP, Chiang SW, Pang CP, Lam DS (2003) The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 44:5293–5300PubMedCrossRefGoogle Scholar
  32. 32.
    Yu SY, Damico FM, Viola F, D’Amico DJ, Young LH (2006) Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 26:531–536PubMedCrossRefGoogle Scholar
  33. 33.
    Enaida H, Hata Y, Ueno A, Nakamura T, Hisatomi T, Miyazaki M, Fujisawa K, Sakamoto T, Ishibashi T (2003) Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina 23:764–770PubMedCrossRefGoogle Scholar
  34. 34.
    Avci R, Kaderli B, Avci B, Simsek S, Baykara M, Kahveci Z, Gelisken O, Yucel AA (2004) Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema. Graefes Arch Clin Exp Ophthalmol 242:845–852PubMedCrossRefGoogle Scholar
  35. 35.
    Kimura T, Kiryu J, Nishiwaki H, Oh H, Suzuma K, Watanabe D, Kurimoto M, Takagi H (2005) Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 25:454–461PubMedCrossRefGoogle Scholar
  36. 36.
    Recchia FM, Ruby AJ, Carvalho Recchia CA (2005) Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol 139:447–454PubMedCrossRefGoogle Scholar
  37. 37.
    Bahadir M, Ertan A, Mertoglu O. (2006) Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol Jun 19; [Epub ahead of print]Google Scholar
  38. 38.
    Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ (2006) Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 26:5–13PubMedCrossRefGoogle Scholar
  39. 39.
    Mochizuki Y, Hata Y, Enaida H, Yoshiyama K, Miyazaki M, Ueno A, Murata T, Sakamoto T, Kubota T, Ishibashi T (2006) Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema. Retina 26:143–148PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Ophthalmology DepartmentUludag University HospitalBursaTurkey
  2. 2.Histology and Embryology DepartmentUludag University HospitalBursaTurkey

Personalised recommendations